Additionally, TPI1 promotes the progression of breast cancer cells by regulating cell division cycle proteins and activating phosphoinositide 3-kinase/AKT serine/threonine kinase 1/mammalian target of rapamycin pathway [52]. Here, MTOR is linked to breast carcinoma.